Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Active and recent NIH-funded research on Atypical Neurofibroma. Data from NIH RePORTER, last 36 months.
Atypical Neurofibroma has emerging NIH research funding with 1 grant totaling $1.4M.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Atypical Neurofibroma. Strongest funded area: Translational / Drug Development. Largest gap: Epidemiology / Natural History.
9 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for atypical neurofibroma. Existing research activity suggests this may be a viable area for grant applications.